SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-10-057177
Filing Date
2010-03-15
Accepted
2010-03-15 17:14:13
Documents
10
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1306632
2 EXECUTIVE INCENTIVE COMPENSATION RECOVERY POLICY dex1053.htm EX-10.53 10866
3 AMENDED AND RESTATED EQUITY COMPENSATION GRANT POLICY dex1054.htm EX-10.54 32706
4 AMENDED AND RESTATED DIRECTOR COMPENSATION POLICY dex1055.htm EX-10.55 26351
5 ACCOUNTANT'S CONSENT dex231.htm EX-23.1 1791
6 CERTIFICATION dex311.htm EX-31.1 7833
7 CERTIFICATION dex312.htm EX-31.2 7760
8 CERTIFICATION dex321.htm EX-32.1 3628
9 CERTIFICATION dex322.htm EX-32.2 3633
10 GRAPHIC g92433g47y05.jpg GRAPHIC 51559
  Complete submission text file 0001193125-10-057177.txt   1473804
Mailing Address 4222 EMPEROR BLVD STE 200 DURHAM NC 27703-8466
Business Address 4222 EMPEROR BLVD STE 200 DURHAM NC 27703-8466 9199419777
INSPIRE PHARMACEUTICALS INC (Filer) CIK: 0001040416 (see all company filings)

IRS No.: 043209022 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-31577 | Film No.: 10682501
SIC: 2834 Pharmaceutical Preparations